Sulbactam sodium/Amoxicillin

舒巴坦钠/阿莫西林

Report date: 2024/01/18 15:18:27

Base Information

Drug NameSulbactam sodium/Amoxicillin
Drug Alias Name舒巴坦匹酯/阿莫西林
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta Lactamase inhibitorsBacterial penicillin-binding protein inhibitors
TargetsBeta LactamaseBacterial penicillin-binding protein
Therapy Area/IndicationsEndocarditisCystitisPyelonephritis +[25] 
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2002/01/14
Country/TerritoryMainland China
CombinationsYes Sulbactam sodiumAmoxicillin
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesLaboratorios Bago SaHarbin Pharmaceutical Group Co Ltd General Pharm Factory
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsEndocarditisCystitisPyelonephritis +[24] 

Other Information

ATC CodeJ01CR02
Related LinksN/A